Periotherapia

Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.

placeOsaka, Osaka, Japan calendar_todayFounded 2017 groups8 employees language periotherapia.co.jp

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace accelerating. Cited 30 times.

YearFilings
20231
20241
20251
20261

Investor mix

2 investors on record.

Investor typeCountShare
Private equity150%
Other / undisclosed150%
Coming soon